{"id":"W2914013411","doi":"10.1093/ecco-jcc/jjy222.080","title":"DOP46 Extended induction treatment with mirikizumab in patients with moderately to severely active ulcerative colitis: results from a Phase 2 trial","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Ulcerative colitis; Medicine; Placebo; Clinical trial; Gastroenterology; Internal medicine; Induction therapy; Surgery; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329041,0.0008897871,0.001768351,0.0001813472,0.0002368621,0.0007997383,0.000428536,0.0008789929,0.003078538],"category_scores_gemma":[0.0007368311,0.0002859764,0.001313249,0.0002284322,0.000423322,0.0005373245,0.0002927068,0.00209756,0.0006826499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002859712,"about_ca_system_score_gemma":0.0004607372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003010781,"about_ca_topic_score_gemma":0.0008487558,"domain_scores_codex":[0.9995742,0.0002251707,0.00003031297,0.00005487597,0.00004467657,0.00007072235],"domain_scores_gemma":[0.9995066,0.00008432411,0.00009326914,0.00004030737,0.00003131648,0.0002441985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8362176,0.01612582,0.00269938,0.001415009,0.001373389,0.0002359729,0.0001726766,0.0006713808,0.03140396,0.0001682198,0.002238099,0.1072786],"study_design_scores_gemma":[0.6796888,0.2935158,0.01942705,0.0001255578,0.0005967572,0.0004226177,0.00004721663,0.0007121939,0.002154398,0.0001763204,0.003083038,0.00005023256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984212,0.01031141,0.0004375916,0.0005172975,0.0002038562,0.0008889717,0.000782488,0.00008120139,0.002565128],"genre_scores_gemma":[0.9884219,0.004824198,0.001120867,0.0008618861,0.0003058892,0.0007992213,0.001586212,0.00001649364,0.002063304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003078538,"threshold_uncertainty_score":0.01029879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008751513302414164,"score_gpt":0.2485763765355697,"score_spread":0.2398248632331555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}